Breaking News Instant updates and real-time market news.

DVAX

Dynavax

$6.36

(0.00%)

16:42
05/23/19
05/23
16:42
05/23/19
16:42

Dynavax trading halted, news pending

  • 30

    May

  • 31

    May

  • 05

    Jun

DVAX Dynavax
$6.36

(0.00%)

02/27/19
CANT
02/27/19
NO CHANGE
Target $28
CANT
Overweight
Dynavax price target raised to $28 from $23 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Dynavax Technologies to $28 following the company's financial and corporate updates from Q4. The analyst is encouraged by the first HEPLISAV-B launch year and expects updates from the SD-101 program to be a key focus for investors during 2019. He reiterates an Overweight rating on Dynavax.
10/22/18
JPMS
10/22/18
NO CHANGE
Target $27
JPMS
Overweight
JPMorgan expects 35%-50% rally in Dynavax after 'clear win' data
JPMorgan analyst Anupam Rama views Dynavax Technologies' update to the SD-101 plus pembrolizumab combination program as a "clear win." The analyst's focus is on the treatment naive melanoma data set, given that the presentation has the most patients at the go-forward 2mg dose level. These data hit the analyst's "upside / homerun scenario" with a 70% overall response rate. Rama sees Dynavax shares trading up in the 35%-50% range following this weekend's update. He keeps an Overweight rating on the name with a $27 price target. The stock in premarket trading is up 21%, or $2.26, to $13.15.
10/22/18
RBCM
10/22/18
NO CHANGE
Target $26
RBCM
Outperform
Dynavax price target raised to $26 from $23 at RBC Capital
RBC Capital analyst Brian Abrahams raised his price target on Dynavax to $26 and kept his Outperform rating after its PD-1 melanoma presentations at the European Society for Medcal Oncology Congress this weekend. The analyst notes that the findings revealed no new safety signals and continued abscopal responses across both PD-L1 positive and negative patients, which he views as the "best-case scenario for this data cut".
10/22/18
CANT
10/22/18
NO CHANGE
Target $32
CANT
Overweight
Dynavax price target raised to $32 from $30 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for Dynavax Technologies (DVAX) to $32 following presentations at the European Society for Medical Oncology Congress. The data present the case for why Merck (MRK) could be a potential partner, Piros tells investors in a research note. He keeps an Overweight rating on Dynavax.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
06/25/19
06/25
10:17
06/25/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
06/25/19
06/25
10:16
06/25/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$97.99

-1.7 (-1.71%)

10:15
06/25/19
06/25
10:15
06/25/19
10:15
Options
UPS put volume heavy and directionally bearish »

Bearish flow noted in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

10:15
06/25/19
06/25
10:15
06/25/19
10:15
General news
U.S. June consumer confidence dropped 9.8 points to 121.5 »

U.S. June consumer…

10:10
06/25/19
06/25
10:10
06/25/19
10:10
General news
FX Action: The dollar »

FX Action: The dollar was…

BAC

Bank of America

$27.59

-0.39 (-1.39%)

10:05
06/25/19
06/25
10:05
06/25/19
10:05
Options
Bank of America call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

10:02
06/25/19
06/25
10:02
06/25/19
10:02
General news
Consumer Confidence data reported »

June Consumer Confidence…

10:02
06/25/19
06/25
10:02
06/25/19
10:02
General news
New Home Sales data reported »

May New Home Sales at…

ACER

Acer Therapeutics

$4.45

-14.72 (-76.79%)

10:02
06/25/19
06/25
10:02
06/25/19
10:02
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

AJG

Arthur J. Gallagher

$86.84

-0.12 (-0.14%)

10:01
06/25/19
06/25
10:01
06/25/19
10:01
Hot Stocks
Arthur J. Gallagher to acquire minority stake in Renomia a.s. »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$75.47

-0.07 (-0.09%)

, S

Sprint

$6.83

-0.03 (-0.44%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Periodicals
Gasparino: T-Mobile, Sprint think 'today could be the day' for DOJ announcement »

FBN's Charles…

TMUS

T-Mobile

$75.47

-0.07 (-0.09%)

S

Sprint

$6.83

-0.03 (-0.44%)

DISH

Dish

$38.13

-0.46 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPDF

PPDAI Group

$4.00

-0.32 (-7.41%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
PPDAI Group falls -7.4% »

PPDAI Group is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$66.87

-11.545 (-14.72%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
AbbVie falls -14.8% »

AbbVie is down -14.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

FTSI

FTS International

$5.30

-0.47 (-8.15%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
FTS International falls -7.5% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USNA

Usana

$79.01

6.605 (9.12%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
Usana rises 9.4% »

Usana is up 9.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$165.05

35.4 (27.30%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
Allergan rises 27.4% »

Allergan is up 27.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYX

Pyxus

$17.20

3.78 (28.17%)

10:00
06/25/19
06/25
10:00
06/25/19
10:00
Hot Stocks
Pyxus rises 27.8% »

Pyxus is up 27.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$9.80

0.47 (5.04%)

09:58
06/25/19
06/25
09:58
06/25/19
09:58
Recommendations
Dova Pharmaceuticals analyst commentary  »

H.C. Wainwright says Dova…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

AGN

Allergan

$165.16

35.51 (27.39%)

, MNK

Mallinckrodt

$8.48

0.06 (0.71%)

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Options
Early notable gainers among liquid option names on June 25th »

Notable gainers among…

AGN

Allergan

$165.16

35.51 (27.39%)

MNK

Mallinckrodt

$8.48

0.06 (0.71%)

MYL

Mylan

$18.16

0.2 (1.11%)

BIIB

Biogen

$239.70

3.81 (1.62%)

CAG

Conagra Brands

$28.53

0.42 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 23

    Jul

FNMA

Fannie Mae

$0.00

(0.00%)

, FMCC

Freddie Mac

$0.00

(0.00%)

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

FNMA

Fannie Mae

$0.00

(0.00%)

FMCC

Freddie Mac

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Subcommittee on…

09:55
06/25/19
06/25
09:55
06/25/19
09:55
Conference/Events
House Committee on Natural Resources to hold a hearing »

The Subcommittee on…

AGN

Allergan

$165.75

36.1 (27.84%)

09:52
06/25/19
06/25
09:52
06/25/19
09:52
Options
Call flow in Allergan last week suggests potential deal leakage »

Call flow in Allergan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHG

InterContinental

$67.24

-0.1 (-0.15%)

, SCHYY

Sands China

$0.00

(0.00%)

09:49
06/25/19
06/25
09:49
06/25/19
09:49
Hot Stocks
InterContinental, Sands China extend partnership »

InterContinental (IHG)…

IHG

InterContinental

$67.24

-0.1 (-0.15%)

SCHYY

Sands China

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AMZN

Amazon.com

$1,914.14

0.71 (0.04%)

, ROKU

Roku

$98.12

-1.86 (-1.86%)

09:49
06/25/19
06/25
09:49
06/25/19
09:49
Periodicals
Amazon introducing three new smart televisions, Ars Technica reports »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,914.14

0.71 (0.04%)

ROKU

Roku

$98.12

-1.86 (-1.86%)

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.